Moderna Inc (MRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,908,000 | 2,595,000 | 1,132,000 | 1,279,000 | 1,623,000 |
| Marketable Securities | 3,297,000 | 3,204,000 | 3,372,000 | 3,852,000 | 4,352,000 |
| Receivables | 71,000 | 184,000 | 1,046,000 | 36,000 | 78,000 |
| Inventories | 146,000 | 153,000 | 332,000 | 240,000 | 128,000 |
| TOTAL | $5,770,000 | $6,544,000 | $6,598,000 | $6,171,000 | $6,766,000 |
| Non-Current Assets | |||||
| PPE Net | 2,086,000 | 2,134,000 | 2,126,000 | 2,169,000 | 2,212,000 |
| Investments And Advances | 2,251,000 | 2,336,000 | 2,143,000 | 2,374,000 | 2,418,000 |
| Other Non-Current Assets | 1,381,000 | 1,324,000 | 1,268,000 | 1,296,000 | 1,308,000 |
| TOTAL | $5,718,000 | $5,794,000 | $5,537,000 | $5,839,000 | $5,938,000 |
| Total Assets | $11,488,000 | $12,338,000 | $12,135,000 | $12,010,000 | $12,704,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 161,000 | 317,000 | 267,000 | 175,000 | 226,000 |
| Accrued Expenses | 1,912,000 | 1,386,000 | 1,178,000 | 987,000 | 1,001,000 |
| Other current liabilities | 220,000 | 185,000 | 73,000 | 192,000 | 252,000 |
| TOTAL | $2,395,000 | $1,987,000 | $1,681,000 | $1,572,000 | $1,604,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 590,000 | 590,000 | N/A | N/A | N/A |
| Deferred Revenues | 102,000 | 99,000 | 163,000 | 218,000 | 125,000 |
| Other Non-Current Liabilities | 928,000 | 938,000 | 941,000 | 942,000 | 941,000 |
| TOTAL | $1,685,000 | $1,701,000 | $1,124,000 | $1,039,000 | $1,034,000 |
| Total Liabilities | $4,080,000 | $3,688,000 | $2,805,000 | $2,611,000 | $2,638,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 396,786 | 394,939 | 390,680 | 389,080 | 386,742 |
| Retained earnings | 5,880,000 | 7,223,000 | 8,049,000 | 8,249,000 | 9,074,000 |
| Other shareholders' equity | 25,000 | 45,000 | 27,000 | 23,000 | 10,000 |
| TOTAL | $7,408,000 | $8,650,000 | $9,330,000 | $9,399,000 | $10,066,000 |
| Total Liabilities And Equity | $11,488,000 | $12,338,000 | $12,135,000 | $12,010,000 | $12,704,000 |